18F-FDG PET/CT在神经母细胞瘤诊疗过程中的价值评估
Evaluation of the Value of 18F-FDG PET/CT in the Diagnosis and Treatment of Neuroblastoma
DOI: 10.12677/acm.2024.1441173, PDF,   
作者: 甘 恩, 李时望*：华中科技大学同济医学院附属协和医院小儿外科，湖北 武汉
关键词: 神经母细胞瘤；18F-FDG PET/CT；小儿实体瘤；诊断；分期；预后；复发监测；Neuroblastoma； 18F-FDG PET/CT； Pediatric Solid Tumors； Diagnosis； Staging； Prognosis； Recurrence Monitoring
摘要: 神经母细胞瘤(Neuroblastoma, NB)是婴幼儿最常见的颅外实体肿瘤，各患儿的临床表现、疗效及预后等方面存在较大差异，肿瘤可自然消退或广泛转移，约有半数患儿就诊时即存在多处转移，分期较晚。18F氟代脱氧葡萄糖正电子发射断层扫描(18F-FDG PET/CT)已经广泛应用于成人肿瘤的诊疗过程中，但在儿童实体肿瘤中的应用相对滞后。本文对近十年来NB的研究进行了文献综述，阐述了18F-FDG PET/CT在NB患儿从诊断、分期、预后、治疗到复发监测整个诊疗过程中的指导意义。
Abstract: Neuroblastoma (NB) is the most common extracranial solid tumor in young children, and there are great differences in the clinical manifestations, efficacy and prognosis of each child. Tumors may resolve spontaneously or metastasize extensively, and about half of children present with multiple metastases and late stage. 18F fluorodeoxyglucose positron emission tomography (18F-FDG PET/CT) has been widely used in the diagnosis and treatment of adult tumors, but its application in pediatric solid tumors is relatively lagging behind. This article reviews the literature on NB in the past decade, and expounds the guiding significance of 18F-FDG PET/CT in the whole diagnosis and treatment of children with NB from diagnosis, staging, prognosis, to recurrence monitoring.
文章引用：甘恩, 李时望. 18F-FDG PET/CT在神经母细胞瘤诊疗过程中的价值评估[J]. 临床医学进展, 2024, 14(4): 1395-1401. https://doi.org/10.12677/acm.2024.1441173

参考文献

[1] 龙俊汕, 张京, 苏小霞, 等. 儿童神经母细胞瘤靶向治疗的研究进展[J]. 临床小儿外科杂志, 2023, 22(7): 619-624.
[2] Liu, J., Si, Y., Zhou, Z., et al. (2022) The Prognostic Value of 18F-FDG PET/CT Intra-Tumoural Metabolic Heterogeneity in Pretreatment Neuroblastoma Patients. Cancer Imaging, 22, Article No. 32. [Google Scholar] [CrossRef] [PubMed]
[3] Pinto, N.R., Applebaum, M.A., Volchenboum, S.L., et al. (2015) Advances in Risk Classification and Treatment Strategies for Neuroblastoma. Journal of Clinical Oncology, 33, 3008-3017. [Google Scholar] [CrossRef] 
[4] Nolan, J.C., Frawley, T., Tighe, J., Soh, H., Curtin, C. and Piskareva, O. (2020) Preclinical Models for Neuroblastoma: Advances and Challenges. Cancer Letters, 474, 53-62. [Google Scholar] [CrossRef] [PubMed]
[5] Brodeur, G.M. (2018) Spontaneous Regression of Neuroblastoma. Cell and Tissue Research, 372, 277-286. [Google Scholar] [CrossRef] [PubMed]
[6] Feng, L., Li, S., Wang, C. and Yang, J. (2023) Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma. Seminars in Nuclear Medicine, 53, 517-529. [Google Scholar] [CrossRef] [PubMed]
[7] Chambers, G., Frood, R., Patel, C. and Scarsbrook, A. (2019) 18F-FDG PET-CT in Paediatric Oncology: Established and Emerging Applications. British Journal of Radiology, 92, Article ID: 20180584. [Google Scholar] [CrossRef] [PubMed]
[8] Howard, B.A. and Wong, T.Z. (2021) 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies. Radiologic Clinics, 59, 737-753. [Google Scholar] [CrossRef] [PubMed]
[9] Paydary, K., Seraj, S.M., Zadeh, M.Z., et al. (2019) The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer. Molecular Imaging and Biology, 21, 1-10. [Google Scholar] [CrossRef] [PubMed]
[10] Vali, R., Alessio, A., Balza, R., et al. (2021) SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0. Journal of Nuclear Medicine, 62, 99-110. [Google Scholar] [CrossRef] [PubMed]
[11] Taggart, D.R., Han, M.M., Quach, A., et al. (2009) Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [18F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response after Iodine-131 MIBG Therapy for Relapsed Neuroblastoma. Journal of Clinical Oncology, 27, 5343-5349. [Google Scholar] [CrossRef] 
[12] Xia, J., Zhang, H., Hu, Q., et al. (2017) Comparison of Diagnosing and Staging Accuracy of PET (CT) and MIBG on Patients with Neuroblastoma: Systemic Review and Meta-Analysis. Current Medical Science, 37, 649-660. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, Y., Xu, Y., Kan, Y., Wang, W. and Yang, J. (2021) Diagnostic Value of Seven Different Imaging Modalities for Patients with Neuroblastic Tumors: A Network Meta-Analysis. Contrast Media & Molecular Imaging, 2021, Article ID: 5333366. [Google Scholar] [CrossRef] [PubMed]
[14] Uslu, L., Donig, J., Link, M., Rosenberg, J., Quon, A. and Daldrup-Link, H.E. (2015) Value of 18F-FDG PET and PET/CT for Evaluation of Pediatric Malignancies. Journal of Nuclear Medicine, 56, 274-286. [Google Scholar] [CrossRef] [PubMed]
[15] Choi, Y.J., Hwang, H.S., Kim, H.J., et al. (2014) 18F-FDG PET as a Single Imaging Modality in Pediatric Neuroblastoma: Comparison with Abdomen CT and Bone Scintigraphy. Annals of Nuclear Medicine, 28, 304-313. [Google Scholar] [CrossRef] [PubMed]
[16] Sharp, S.E., Shulkin, B.L., Gelfand, M.J., Salisbury, S. and Furman, W.L. (2009) 123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma. Journal of Nuclear Medicine, 50, 1237-1243. [Google Scholar] [CrossRef] [PubMed]
[17] Li, H.F., Mao, H.J., Zhao, L., Guo, D.L., Chen, B. and Yang, J.F. (2020) The Diagnostic Accuracy of PET(CT) in Patients with Neuroblastoma: A Meta-Analysis and Systematic Review. Journal of Computer Assisted Tomography, 44, 111-117. [Google Scholar] [CrossRef] 
[18] Yağci-Küpeli, B., Koçyiğit-Deveci, E., Adamhasan, F. and Küpeli, S. (2019) The Value of 18F-FDG PET/CT in Detecting Bone Marrow Involvement in Childhood Cancers. Journal of Pediatric Hematology/Oncology, 41, 438-441. [Google Scholar] [CrossRef] 
[19] Zapata, C.P., Cuglievan, B., Zapata, C.M., et al. (2018) PET/CT versus Bone Marrow Biopsy in the Initial Evaluation of Bone Marrow Infiltration in Various Pediatric Malignancies. Pediatric Blood & Cancer, 65, e26814. [Google Scholar] [CrossRef] [PubMed]
[20] Feng, L., Yang, X., Lu, X., et al. (2022) 18F-FDG PET/CT-Based Radiomics Nomogram Could Predict Bone Marrow Involvement in Pediatric Neuroblastoma. Insights into Imaging, 13, Article No. 144. [Google Scholar] [CrossRef] [PubMed]
[21] Shah, S., Purandare, N., Kembhavi, S., et al. (2022) FDG PETCT for Assessing Marrow Involvement at Staging Pediatric Nonhematological Round Cell Malignancies. Nuclear Medicine Communications, 43, 56-63. [Google Scholar] [CrossRef] 
[22] Monclair, T., Brodeur, G.M., Ambros, P.F., et al. (2009) The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report. Journal of Clinical Oncology, 27, 298-303. [Google Scholar] [CrossRef] 
[23] Liu, J., Li, C., Yang, X., et al. (2022) The Diagnostic Value of 18F-FDG PET/CT Bone Marrow Uptake Pattern in Detecting Bone Marrow Involvement in Pediatric Neuroblastoma Patients. Contrast Media & Molecular Imaging, 2022, Article ID: 7556315. [Google Scholar] [CrossRef] [PubMed]
[24] Dhull, V.S., Sharma, P., Patel, C., et al. (2015) Diagnostic Value of 18F-FDG PET/CT in Paediatric Neuroblastoma: Comparison with 131I-MIBG Scintigraphy. Nuclear Medicine Communications, 36, 1007-1013. [Google Scholar] [CrossRef] 
[25] Ishiguchi, H., Ito, S., Kato, K., et al. (2018) Diagnostic Performance of 18F-FDG PET/CT and Whole-Body Diffusion-Weighted Imaging with Background Body Suppression (DWIBS) in Detection of Lymph Node and Bone Metastases from Pediatric Neuroblastoma. Annals of Nuclear Medicine, 32, 348-362. [Google Scholar] [CrossRef] [PubMed]
[26] Ko, K.Y., Yen, R.F., Ko, C.L., et al. (2022) Prognostic Value of Interim 18F-DOPA and 18F-FDG PET/CT Findings in Stage 3-4 Pediatric Neuroblastoma. Clinical Nuclear Medicine, 47, 21-25. [Google Scholar] [CrossRef] 
[27] Sung, A.J., Weiss, B.D., Sharp, S.E., Zhang, B. and Trout, A.T. (2021) Prognostic Significance of Pretreatment F-FDG Positron Emission Tomography/Computed Tomography in Pediatric Neuroblastoma. Pediatric Radiology, 51, 1400-1405. [Google Scholar] [CrossRef] [PubMed]
[28] Qian, L., Yang, S., Zhang, S., et al. (2022) Prediction of MYCN Amplification, 1p and 11q Aberrations in Pediatric Neuroblastoma via Pre-Therapy 18F-FDG PET/CT Radiomics. Frontiers in Medicine, 9, Article 840777. [Google Scholar] [CrossRef] [PubMed]
[29] Man, S., Yan, J., Li, J., et al. (2021) Value of Pretreatment 18F-FDG PET/CT in Prognosis and the Reflection of Tumor Burden: A Study in Pediatric Patients with Newly Diagnosed Neuroblastoma. International Journal of Medical Sciences, 18, 1857-1865. [Google Scholar] [CrossRef] [PubMed]
[30] Li, C., Zhang, J., Chen, S., et al. (2018) Prognostic Value of Metabolic Indices and Bone Marrow Uptake Pattern on Preoperative 18F-FDG PET/CT in Pediatric Patients with Neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging, 45, 306-315. [Google Scholar] [CrossRef] [PubMed]
[31] 中国抗癌协会小儿肿瘤专业委员会, 中华医学会小儿外科学分会肿瘤学组. 儿童神经母细胞瘤诊疗专家共识CCCG-NB-2021方案[J]. 中华小儿外科杂志, 2022, 43(7): 588-598.
[32] Wienke, J., Dierselhuis, M.P., Tytgat, G.A.M., Künkele, A., Nierkens, S. and Molenaar, J.J. (2021) The Immune Landscape of Neuroblastoma: Challenges and Opportunities for Novel Therapeutic Strategies in Pediatric Oncology. European Journal of Cancer, 144, 123-150. [Google Scholar] [CrossRef] [PubMed]
[33] Kushner, B.H., Yeung, H.W., Larson, S.M., Kramer, K. and Cheung, N.K. (2001) Extending Positron Emission Tomography Scan Utility to High-Risk Neuroblastoma: Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography as Sole Imaging Modality in Follow-Up of Patients. Journal of Clinical Oncology, 19, 3397-3405. [Google Scholar] [CrossRef] 
[34] Sato, Y., Kurosawa, H., Sakamoto, S., et al. (2015) Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography for Follow-Up of 13-Cis-Retinoic Acid Treatment for Residual Neuroblastoma after Myeloablative Chemotherapy. Medicine, 94, e1290. [Google Scholar] [CrossRef] 
[35] Skoura, E., Oikonomopoulos, G., Vasileiou, S., Kyprianou, D., Koumakis, G. and Datseris, I.E. (2014) 18F-FDG-PET/CT, (123)I-MIBG and (99m)Tc-MDP Whole-Body Scans, in Detecting Recurrence of an Adult Adrenal Neuroblastoma. Hellenic Journal of Nuclear Medicine, 17, 58-61.
[36] Feng, L., Qian, L., Yang, S., et al. (2022) Clinical Parameters Combined with Radiomics Features of PET/CT Can Predict Recurrence in Patients with High-Risk Pediatric Neuroblastoma. BMC Medical Imaging, 22, Article No. 102. [Google Scholar] [CrossRef] [PubMed]

为你推荐